Skip to main content
Premium Trial:

Request an Annual Quote

Healthcare Costs Sap Biotech VC

The Washington Post's Christopher Weaver says that, "over the past two decades, venture capitalists helped make possible striking advances in health care, including robotic surgery, cancer vaccines, and genomics." But US healthcare spending is "forecasted to grow in an unaffordable way for the country," says John Doerr from Kleiner Perkins Caufield & Byers -- a situation making more VCs focus on supporting companies that could help cut those costs, according to Weaver. "The share of venture dollars flowing to seed and early-stage investments in biotechnology and medical devices has plummeted since 2007," Weaver says, adding that "biotechnology faces its own set of problems." Chief among them, RBC Capital Markets' Michael Yee tells the Post, is that the industry "is cognizant of the fact that the health system is moving towards a more cost-conscious system." For Highland Capital Partners' Bob Higgins, who teaches a healthcare entrepreneurship class at Harvard Business School, "a few years ago, the 'classic' prospective employer for his students was an emerging biotech firm," Weaver says. "But few of those companies are now hiring."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.